This 15-minute presentation introduces Flash Oxidation (Fox®) Protein Footprinting as a tool to accelerate early-stage monoclonal antibody drug discovery. The technology generates high-resolution data for epitope and paratope mapping, helping researchers understand how biotherapeutics interact with their targets and identify potential failure modes like protein aggregation. A three-step workflow delivers actionable insights into protein structure and stability across both classical and AI-driven screening processes.

Presented by Scot Weinberger, CEO & Founder, GenNext Technologies

Scot Weinberger is a prolific inventor and entrepreneur who holds 22 patents spanning chromatography, mass spectrometry, and label-free biosensing technologies. He has authored more than 30 publications with 2,000 citations in the fields of translational medicine and life science research. Scot successfully co-founded multiple biotech companies, including Linear Instruments, Ciphergen Biosystems, Molecular Sensing, and GenNext Technologies.